The Effect of Endothelin Receptor Antagonists in Patients with Eisenmenger Syndrome: A Systematic Review
ConclusionsThis study demonstrated safety and improved hemodynamic effects of bosentan in ES, with a controversial effect on exercise capacity. Further randomized controlled trials with longer follow-up duration are needed to confirm these results.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Academies | Cardiology | Cardiovascular | Clinical Trials | Databases & Libraries | Heart | International Medicine & Public Health | Science | Sports Medicine | Study | Viagra | WHO